Association between HLA-B*58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong

The British Journal of Dermatology
M L S ChiuB Tomlinson

Abstract

Allopurinol has been reported as a common cause of severe cutaneous adverse reactions (SCARs). Recent studies in various populations suggest that HLA-B*58:01 is a strong genetic marker for allopurinol-induced SCAR, especially in populations with a high frequency of HLA-B*58:01. To confirm the association link between HLA-B*58:01 and hypersensitivity reactions attributed to allopurinol use in Han Chinese patients in Hong Kong. We performed a case-control study to investigate whether the HLA-B*58:01 allele predisposes to allopurinol-induced SCAR in Han Chinese patients in Hong Kong. The HLA-B*58:01 genotyping was performed in 20 patients with allopurinol-induced SCAR or erythema multiforme major (EMM; n = 1) and in 30 patients tolerant to allopurinol. All of the 19 patients with allopurinol-induced SCAR examined but not the patient with EMM carried HLA-B*58:01 whereas only four (13%) of the control patients had this allele. The positive rate of the HLA-B*58:01 was significantly higher in the cases than in the allopurinol-tolerant control group [odds ratio (OR) 123·5, 95% confidence interval (CI) 12·8-1195·1; P < 1 × 10(-4) ] and was even higher after removal of the patient with EMM (OR 229·7, 95% CI 11·7-4520·4). The sensitivity ...Continue Reading

References

Dec 14, 1995·The New England Journal of Medicine·J C RoujeauF Locati
Nov 10, 1994·The New England Journal of Medicine·J C Roujeau, R S Stern
Mar 1, 1993·The Annals of Pharmacotherapy·F Arellano, J A Sacristán
Feb 15, 1996·The New England Journal of Medicine·B T Emmerson
Jul 17, 1998·Clinical and Experimental Dermatology·H HamanakaM Shimizu
May 1, 2002·Current Opinion in Rheumatology·Robert L Wortmann
Jul 17, 2003·American Journal of Clinical Dermatology·Nicolas Bachot, Jean-Claude Roujeau
May 1, 1956·Annals of Human Genetics·J B HALDANE
Mar 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Shuen-Iu HungYuan-Tsong Chen
Mar 16, 2006·Pharmacogenetics and Genomics·Shuen-Iu HungYuan-Tsong Chen
Aug 3, 2006·The British Journal of Dermatology·H PeyrièreUNKNOWN Network of the French Pharmacovigilance Centers
Jul 28, 2007·Clinical Pharmacokinetics·Richard O DayKenneth M Williams
Oct 9, 2007·Journal of the American Academy of Dermatology·Sima HalevyUNKNOWN EuroSCAR Study Group
Jan 15, 2008·Pharmacogenetics and Genomics·Christine LonjouUNKNOWN RegiSCAR study group
Feb 8, 2008·The New England Journal of Medicine·Simon MallalUNKNOWN PREDICT-1 Study Team
Mar 20, 2009·Current Rheumatology Reports·Jeannie Chao, Robert Terkeltaub
Jul 7, 2010·Pharmacogenomics·Elizabeth J Phillips, Simon A Mallal
Feb 9, 2011·Pharmacogenetics and Genomics·Hye-Ryun KangUNKNOWN Adverse Drug Reaction Research Group in Korea
Mar 12, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jae-Woo JungHye-Ryun Kang
Oct 25, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·L AtzoriN Aste

❮ Previous
Next ❯

Citations

Aug 21, 2013·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·S StänderT Schwarz
Apr 3, 2013·Annales de dermatologie et de vénéréologie·A Petit
Aug 28, 2012·Pharmacogenomics·Rebecca PavlosElizabeth Phillips
Feb 26, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Rebecca PavlosElizabeth Phillips
Jul 23, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Sheena N RamasamyRichard O Day
Oct 24, 2012·Advances in Chronic Kidney Disease·John S Sundy
Sep 12, 2013·Journal of Clinical Pharmacy and Therapeutics·Y-L YangB Tomlinson
Apr 17, 2015·Pharmacogenomics·Rebecca L Roberts, Lisa K Stamp
Mar 22, 2016·The Journal of Investigative Dermatology·Chau Yee NgUNKNOWN Taiwan Severe Cutaneous Adverse Reaction Consortium
May 17, 2017·Pharmacogenetics and Genomics·Niwat SaksitWongwiwat Tassaneeyakul
Jun 20, 2014·International Journal of Clinical Practice·K H K Patel, D J A Goldsmith
Jan 17, 2017·International Journal of Immunogenetics·G S GhattaorayaA Alfirevic
Jan 11, 2018·Toxicological Sciences : an Official Journal of the Society of Toxicology·Binbin SongKousei Ito
Apr 12, 2018·Pharmacogenetics and Genomics·Heng ChengYouming Zhang
Jun 12, 2018·Current Opinion in Allergy and Clinical Immunology·Andrew GibsonMunir Pirmohamed
Mar 4, 2017·The British Journal of Dermatology·N R AdlerE J Phillips
Jan 1, 2014·Current Opinion in Rheumatology·Lisa K Stamp
Jun 11, 2014·Pharmacogenetics and Genomics·Ellen M McDonaghTeri E Klein
Mar 21, 2017·Drug Metabolism and Personalized Therapy·Ingrid Fricke-GalindoMarisol López-López
Dec 3, 2015·The American Journal of Dermatopathology·Margarida M GonçaloÓscar E Tellechea
Feb 21, 2018·Expert Opinion on Drug Metabolism & Toxicology·A SullivanD J Naisbitt
Jul 19, 2019·International Journal of Rheumatic Diseases·Jing WuQing-Hong Yu
Feb 27, 2020·Asia Pacific Allergy·Bernard Yu-Hor ThongRuby Pawankar
Jul 12, 2017·Immunogenetics·Patricia T IllingJames McCluskey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.